| MeSH term | MeSH ID | Detail |
|---|---|---|
| Prosthesis-Related Infections | D016459 | 7 associated lipids |
| Fibrosis | D005355 | 23 associated lipids |
| Tooth Discoloration | D014075 | 7 associated lipids |
| Sinusitis | D012852 | 9 associated lipids |
| Fusobacterium Infections | D005674 | 3 associated lipids |
| Enterocolitis, Pseudomembranous | D004761 | 8 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Urinary Tract Infections | D014552 | 11 associated lipids |
| Cross Infection | D003428 | 9 associated lipids |
| Pseudomonas Infections | D011552 | 25 associated lipids |
clarithromycin
clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.
Cross Reference
Introduction
To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with clarithromycin?
clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (63)
- J. Antimicrob. Chemother. (56)
- J. Clin. Microbiol. (39)
- Others (258)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with clarithromycin
PubChem Associated disorders and diseases
What pathways are associated with clarithromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with clarithromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- J. Antimicrob. Chemother. (25)
- Antimicrob. Agents Chemother. (20)
- J. Clin. Microbiol. (9)
- Others (66)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with clarithromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with clarithromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with clarithromycin?
Related references are published most in these journals:
- J. Antimicrob. Chemother. (20)
- Antimicrob. Agents Chemother. (17)
- J. Clin. Microbiol. (13)
- Others (57)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with clarithromycin?
Mouse Model
Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).
Knock-out
Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).
Experimental Pneumococcal Meningitis
Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (2)
- J. Antimicrob. Chemother. (1)
- Clin. Diagn. Lab. Immunol. (1)
- Others (2)
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with clarithromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Farup PG | [Treatment of Helicobacter pylori infection--results and experiences with an Internet-based collaboration trial]. | 2003 | Tidsskr. Nor. Laegeforen. | pmid:14714012 |
| Brown CS et al. | Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs. | 2004 | Clin Pharmacokinet | pmid:14715050 |
| Cengiz AB et al. | Fatal necrotizing pneumonia caused by group A streptococcus. | 2004 Jan-Feb | J Paediatr Child Health | pmid:14718011 |
| Darkes MJ and Perry CM | Clarithromycin extended-release tablet: a review of its use in the management of respiratory tract infections. | 2003 | Am J Respir Med | pmid:14720016 |
| Keicho N and Kudoh S | Diffuse panbronchiolitis: role of macrolides in therapy. | 2002 | Am J Respir Med | pmid:14720066 |
| Wu JC et al. | Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial. | 2004 | Gut | pmid:14724146 |
| Lahey T | Invasive Mycobacterium marinum infections. | 2003 | Emerging Infect. Dis. | pmid:14725262 |
| Erard V et al. | Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumonia. | 2004 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:14727149 |
| Okimoto N et al. | [Clinical features of Q fever pneumonia]. | 2003 | Nihon Kokyuki Gakkai Zasshi | pmid:14727547 |
| Aktan B et al. | Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion. | 2003 Nov-Dec | Pol J Pharmacol | pmid:14730107 |
| Hirata T et al. | Suppression of postoperative systemic inflammatory response syndrome with clarithromycin following lung cancer surgery. | 2004 Jan-Feb | Eur Surg Res | pmid:14730218 |
| OrtÃz-DomÃnguez A et al. | A case of clarithromycin-induced manic episode (antibiomania). | 2004 | Int. J. Neuropsychopharmacol. | pmid:14731313 |
| Kafetzis DA et al. | Failure to eradicate Group A beta-haemolytic streptococci (GABHS) from the upper respiratory tract after antibiotic treatment. | 2004 | Int. J. Antimicrob. Agents | pmid:14732316 |
| Löffler D and Ternes TA | Determination of acidic pharmaceuticals, antibiotics and ivermectin in river sediment using liquid chromatography-tandem mass spectrometry. | 2003 | J Chromatogr A | pmid:14735982 |
| de Korwin JD | [Helicobacter pylori infection and antimicrobial agents resistance]. | 2004 | Rev Med Interne | pmid:14736561 |
| Uzun C | Tinnitus due to clarithromycin. | 2003 | J Laryngol Otol | pmid:14738620 |
| Chu SY et al. | Clarithromycin pharmacokinetics in healthy young and elderly volunteers. | 1992 | J Clin Pharmacol | pmid:1474166 |
| Gelber RH et al. | Clarithromycin at very low levels and on intermittent administration inhibits the growth of M. leprae in mice. | 1992 | Int. J. Lepr. Other Mycobact. Dis. | pmid:1474290 |
| Cammarota G et al. | High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levofloxacin, for Helicobacter pylori eradication. | 2004 | J. Clin. Gastroenterol. | pmid:14745283 |
| Desimone JA et al. | Treatment of Mycobacterium avium complex immune reconstitution disease in HIV-1-infected individuals. | 2003 | AIDS Patient Care STDS | pmid:14746655 |
| González Carro P et al. | [Efficacy of Helicobacter pylori eradication in non-ulcer dyspepsia]. | 2004 | Med Clin (Barc) | pmid:14746696 |
| Brans R et al. | [Cutaneous infection with Mycobacterium marinum. successful therapy with rifampicin and clarithromycin]. | 2004 | Hautarzt | pmid:14749869 |
| Furuta T et al. | Simultaneous determination of 6beta-hydroxycortisol and cortisol in human urine by liquid chromatography with ultraviolet absorbance detection for phenotyping the CYP3A activity determined by the cortisol 6beta-hydroxylation clearance. | 2004 | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | pmid:14751784 |
| González Carro P et al. | Acute pancreatitis and modified-release clarithromycin. | 2004 | Ann Pharmacother | pmid:14755067 |
| Wallwork B et al. | Effect of clarithromycin on nuclear factor-kappa B and transforming growth factor-beta in chronic rhinosinusitis. | 2004 | Laryngoscope | pmid:14755204 |
| Garcés-Sánchez M et al. | [Epidemiology and burden of acute otitis media in Valencia (Spain)]. | 2004 | An Pediatr (Barc) | pmid:14757015 |
| Garau J | Performance in practice: bacteriological efficacy in patients with drug-resistant S. pneumoniae. | 2004 | Clin. Microbiol. Infect. | pmid:14759231 |
| Hamaguchi K et al. | Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication. | 2004 | Langenbecks Arch Surg | pmid:14767774 |
| Saeki S et al. | [A case of pulmonary Mycobacterium gordonae infection with pleural effusion]. | 2004 | Nihon Kokyuki Gakkai Zasshi | pmid:14768374 |
| Ji B et al. | Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy. | 1992 | Antimicrob. Agents Chemother. | pmid:1482155 |
| Rastogi N and Goh KS | Effect of pH on radiometric MICs of clarithromycin against 18 species of mycobacteria. | 1992 | Antimicrob. Agents Chemother. | pmid:1482156 |
| Rastogi N et al. | Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol. | 1992 | Antimicrob. Agents Chemother. | pmid:1482157 |
| Derouin F et al. | Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis. | 1992 | Antimicrob. Agents Chemother. | pmid:1482160 |
| De Francesco V et al. | Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure. | 2004 | Aliment. Pharmacol. Ther. | pmid:14871280 |
| Gotfried MH | Macrolides for the treatment of chronic sinusitis, asthma, and COPD. | 2004 | Chest | pmid:14872001 |
| Wozniak DJ and Keyser R | Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. | 2004 | Chest | pmid:14872002 |
| Anim-Appiah D et al. | Mycobacterium avium complex tenosynovitis of the wrist and hand. | 2004 | Arthritis Rheum. | pmid:14872467 |
| Chu SY et al. | Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses. | 1992 | Antimicrob. Agents Chemother. | pmid:1489187 |
| Araujo FG et al. | Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. | 1992 | Antimicrob. Agents Chemother. | pmid:1489188 |
| Gan VN et al. | Pharmacokinetics of a clarithromycin suspension in infants and children. | 1992 | Antimicrob. Agents Chemother. | pmid:1489191 |
| Gálvez-Múgica MA et al. | [Meta-analysis of clarithromycin compared to other antibiotics for the treatment of lower respiratory tract infections]. | 2003 | Rev Esp Quimioter | pmid:14961134 |
| Kogan EA et al. | [The role of apoptosis and proliferation of epitheliocytes in morphogenesis of Helicobacter pylori-associated gastritis]. | 2003 Nov-Dec | Arkh. Patol. | pmid:14964963 |
| Saltanova SD and Tkach OS | [Efficacy of anti-Helicobacter therapy in children with ulcer-like functional dyspepsia]. | 2003 | Lik. Sprava | pmid:14965005 |
| Kahri AJ et al. | Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin. | 2004 | Ann Pharmacother | pmid:14966253 |
| Yang KC et al. | Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer. | 2003 | J. Formos. Med. Assoc. | pmid:14976565 |
| Ferrara AM and Fietta AM | New developments in antibacterial choice for lower respiratory tract infections in elderly patients. | 2004 | Drugs Aging | pmid:14979735 |
| Chiba N et al. | Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia. | 2004 | Aliment. Pharmacol. Ther. | pmid:14984382 |
| Isakov VA et al. | [Comparative analysis of the effectiveness of two Helicobacter pylori eradication plans based on omeprazole, clarithromycin and amoxicillin in patients with duodenal peptic ulcer: results of a randomized double-blind, controlled study]. | 2003 | Eksp Klin Gastroenterol | pmid:14989295 |
| Zakharova NV | [Clarithromycin--standard component of anti-Helicobacter therapy]. | 2003 | Eksp Klin Gastroenterol | pmid:14989297 |
| He XX et al. | [Effect of CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with rabeprazole-based triple therapy in Chinese]. | 2004 | Zhonghua Nei Ke Za Zhi | pmid:14990013 |
| Kobashi Y and Matsushima T | Comparison of clinical features in patients with pulmonary Mycobacterium-avium complex (MAC) disease treated before and after proposal for guidelines. | 2004 | J. Infect. Chemother. | pmid:14991514 |
| Kasahara K et al. | Longterm azithromycin therapy for three patients with chronic lower respiratory tract infections. | 2004 | J. Infect. Chemother. | pmid:14991517 |
| Gumurdulu Y et al. | Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. | 2004 | World J. Gastroenterol. | pmid:14991935 |
| Guo CY et al. | Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection. | 2004 | World J. Gastroenterol. | pmid:14991953 |
| Mathers Dunbar L et al. | Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults. | 2004 | Clin Ther | pmid:14996517 |
| Calabresi L et al. | Pharmacokinetic interactions between omeprazole/pantoprazole and clarithromycin in health volunteers. | 2004 | Pharmacol. Res. | pmid:14998561 |
| Athamna A et al. | In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis. | 2004 | J. Antimicrob. Chemother. | pmid:14998982 |
| Wilson R et al. | Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. | 2004 | Chest | pmid:15006954 |
| Fujiki R et al. | [Clinical efficacy of oral clarithromycin monotherapy in patients with mild or moderate community-acquired pneumonia]. | 2003 | Jpn J Antibiot | pmid:15007880 |
| Gisbert JP et al. | Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study. | 2004 Jan-Feb | Hepatogastroenterology | pmid:15011890 |
| Bermejo Vicedo T et al. | [A pharmacoeconomic study of in-hospital treatment against community-acquired pneumonia]. | Farm Hosp | pmid:15012176 | |
| Reato G et al. | Immunomodulating effect of antimicrobial agents on cytokine production by human polymorphonuclear neutrophils. | 2004 | Int. J. Antimicrob. Agents | pmid:15013040 |
| Bouchillon SK et al. | In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study. | 2004 | Int. J. Antimicrob. Agents | pmid:15013045 |
| Sezer S et al. | Association of helicobacter pylori infection with nutritional status in hemodialysis patients. | 2004 Jan-Feb | Transplant. Proc. | pmid:15013297 |
| Gluais P et al. | Clarithromycin reduces Isus and Ito currents in human atrial myocytes with minor repercussions on action potential duration. | 2003 | Fundam Clin Pharmacol | pmid:15015714 |
| Furuta T et al. | Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy. | 2004 | Clin. Gastroenterol. Hepatol. | pmid:15017629 |
| Qasim A et al. | Pretreatment antimicrobial susceptibility testing is not cost saving in the standard eradication of Helicobacter pylori. | 2004 | Clin. Gastroenterol. Hepatol. | pmid:15017637 |
| Romano M et al. | Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori. | 2003 | Clin. Gastroenterol. Hepatol. | pmid:15017668 |
| Peitz U et al. | [Long-term course of reflux symptoms following Helicobacter pylori eradication]. | 2004 | Dtsch. Med. Wochenschr. | pmid:15026962 |
| Bormann G and Marsch WC | [Sporotrichoid atypical mycobacterial infections. Antibiotic monotherapy]. | 2004 | Hautarzt | pmid:15029437 |
| Wong RS and Hui DS | Index patient and SARS outbreak in Hong Kong. | 2004 | Emerging Infect. Dis. | pmid:15030708 |
| Sugiyama T and Asaka M | [Eradication effect of lansoprazole-based triple therapy against H. pylori]. | 2004 | Nippon Rinsho | pmid:15038091 |
| Abshire R et al. | Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment. | 2004 | Clin Ther | pmid:15038942 |
| Yang GG et al. | SARS-associated coronavirus infection in teenagers. | 2004 | Emerging Infect. Dis. | pmid:15043016 |
| Jung S et al. | Balamuthia mandrillaris meningoencephalitis in an immunocompetent patient: an unusual clinical course and a favorable outcome. | 2004 | Arch. Pathol. Lab. Med. | pmid:15043486 |
| Cammarota G et al. | High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection. | 2004 | Aliment. Pharmacol. Ther. | pmid:15043520 |
| Conway SP et al. | Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis. | 2004 | J. Antimicrob. Chemother. | pmid:15044430 |
| Jüttner S et al. | Reliable detection of macrolide-resistant Helicobacter pylori via fluorescence in situ hybridization in formalin-fixed tissue. | 2004 | Mod. Pathol. | pmid:15044917 |
| Hassmann-Poznańska E et al. | [Efficacy of clarithromycin (Fromilid) in treatment of uncomplicated acute bacterial rhinosinusitis in children]. | 2003 | Otolaryngol Pol | pmid:15049183 |
| Masuda H et al. | Characteristics and trends of clarithromycin-resistant Helicobacter pylori isolates in Japan over a decade. | 2004 | Pathobiology | pmid:15051929 |
| Lai YC et al. | Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers. | 2004 | World J. Gastroenterol. | pmid:15052680 |
| Hao Q et al. | New mutation points in 23S rRNA gene associated with Helicobacter pylori resistance to clarithromycin in northeast China. | 2004 | World J. Gastroenterol. | pmid:15052698 |
| Hersh EV and Moore PA | Drug interactions in dentistry: the importance of knowing your CYPs. | 2004 | J Am Dent Assoc | pmid:15058617 |
| Englund G et al. | Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring. | 2004 | BMC Med | pmid:15061868 |
| Kornienko EA and Klochko OG | [Comparative efficacy of proton pump inhibitors in children]. | 2003 | Eksp Klin Gastroenterol | pmid:15065532 |
| Hjalmarsson S et al. | Rapid combined characterization of microorganism and host genotypes using a single technology. | 2004 | Helicobacter | pmid:15068415 |
| Drago L et al. | Effect of moxifloxacin on bacterial pathogenicity factors in comparison with amoxicillin, clarithromycin and ceftriaxone. | 2004 | J Chemother | pmid:15077996 |
| Malerczyk C et al. | Serum bactericidal activity of gemifloxacin versus clarithromycin against Streptococcus pneumoniae with different susceptibility to quinolones. | 2004 | J Chemother | pmid:15078000 |
| Demartini G et al. | Effect of multiple doses of clarithromycin and amoxicillin on IL-6, IFNgamma and IL-10 plasma levels in patients with community acquired pneumonia. | 2004 | J Chemother | pmid:15078004 |
| Sopena N et al. | Comparative study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of community-acquired pneumonia in adults. | 2004 | J Chemother | pmid:15078008 |
| Elviss NC et al. | Application of 3'-mismatched reverse primer PCR compared with real-time PCR and PCR-RFLP for the rapid detection of 23S rDNA mutations associated with clarithromycin resistance in Helicobacter pylori. | 2004 | Int. J. Antimicrob. Agents | pmid:15081083 |
| Koeth LM et al. | Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000. | 2004 | Int. J. Antimicrob. Agents | pmid:15081084 |
| Koh WJ et al. | Six-month therapy with aerosolized interferon-gamma for refractory multidrug-resistant pulmonary tuberculosis. | 2004 | J. Korean Med. Sci. | pmid:15082886 |
| Beck J | Efficacy of esomeprazole in patients with acid-peptic disorders. | Gastroenterol Nurs | pmid:15082946 | |
| Rao KB et al. | Enhanced hypoprothrombinemia with warfarin due to azithromycin. | 2004 | Ann Pharmacother | pmid:15084685 |
| Candelli M et al. | Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes. | 2004 | J. Pediatr. Gastroenterol. Nutr. | pmid:15085021 |
| Shirin H et al. | Application of Maastricht 2-2000 guidelines for the management of Helicobacter pylori among specialists and primary care physicians in israel: are we missing the malignant potential of Helicobacter pylori? | 2004 | J. Clin. Gastroenterol. | pmid:15087690 |
| Sharma VK and Howden CW | A national survey of primary care physicians' perceptions and practices related to Helicobacter pylori infection. | 2004 | J. Clin. Gastroenterol. | pmid:15087691 |
| Nomura S et al. | The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura. | 2004 | Eur. J. Haematol. | pmid:15089773 |
| Gisbert JP et al. | Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis. | 2004 | Eur J Gastroenterol Hepatol | pmid:15095858 |